Guardant Health Stock In The News
| GH Stock | USD 47.65 0.61 1.26% |
Our overall analysis of Guardant Health's news coverage and content from conventional and social sources shows investors' bearish mood towards Guardant Health. The specific impact of Guardant Health news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Guardant Health's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Guardant Health headlines in addition to utilizing other, more conventional financial analysis modules. Check out Guardant Health Backtesting and Guardant Health Hype Analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Guardant |
Guardant Health Today Top News and Investor Outlook
Guardant Health Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Guardant and other traded companies coverage with news coverage. We help investors stay connected with Guardant headlines for the 30th of January to make an informed investment decision based on correlating the impacts of news items on Guardant Stock performance. Please note that trading solely based on the Guardant Health hype is not for everyone as timely availability and quick action are needed to avoid losses.
Guardant Health stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Guardant earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Guardant Health that are available to investors today. That information is available publicly through Guardant media outlets and privately through word of mouth or via Guardant internal channels. However, regardless of the origin, that massive amount of Guardant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Guardant Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Guardant Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Guardant Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Guardant Health alpha.
Guardant Largest EPS Surprises
Earnings surprises can significantly impact Guardant Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-02-24 | 2019-12-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2019-03-12 | 2018-12-31 | -0.35 | -0.3 | 0.05 | 14 | ||
2019-05-09 | 2019-03-31 | -0.37 | -0.3 | 0.07 | 18 | ||
2024-05-09 | 2024-03-31 | -0.85 | -0.94 | -0.09 | 10 | ||
2024-08-07 | 2024-06-30 | -0.74 | -0.84 | -0.1 | 13 | ||
2020-05-07 | 2020-03-31 | -0.39 | -0.29 | 0.1 | 25 |
Guardant Health Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Guardant Health Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
29th of January 2025
The Goldman Sachs Group Issues Positive Forecast for Guardant Health Stock Price - MarketB... at news.google.com
17th of January 2025
Disposition of 711 shares by Eagle Craig of Guardant Health at 34.76 subject to Rule 16b-3 at Eagle Craig
16th of January 2025
Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Cli... at businesswire.com
15th of January 2025
Disposition of 3309 shares by Michael Bell of Guardant Health subject to Rule 16b-3 at Michael Bell
14th of January 2025
Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection, Diagnosis, an... at businesswire.com
13th of January 2025
Guardant Health announces prelim Q4 revenue above estimate at seekingalpha.com
7th of January 2025
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institutes Vangu... at businesswire.com
6th of January 2025
Guardant Health Inc Shares Up 9.54 percent on Jan 6 at gurufocus.com
3rd of January 2025
Disposition of 2084 shares by Michael Bell of Guardant Health subject to Rule 16b-3 at MacroaxisInsider
2nd of January 2025
Guardant Health Inc to Present at 43rd Annual J.P. Morgan Healthcare Conference at gurufocus.com
31st of December 2024
Disposition of 94555 shares by Helmy Eltoukhy of Guardant Health subject to Rule 16b-3 at Helmy Eltoukhy
13th of December 2024
Acquisition by Tariq Musa of 250 shares of Guardant Health subject to Rule 16b-3 at Tariq Musa
29th of November 2024
Disposition of 316 shares by Darya Chudova of Guardant Health subject to Rule 16b-3 at Darya Chudova
19th of November 2024
Guardant Health Inc Shares Up 5.46 percent on Nov 19 at gurufocus.com
18th of November 2024
Disposition of 7000 shares by Kumud Kalia of Guardant Health at 29.246 subject to Rule 16b... at Kumud Kalia
12th of November 2024
Disposition of 8435 shares by Clark Ian T of Guardant Health subject to Rule 16b-3 at Clark Ian T
8th of November 2024
Guardant Health Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags at finance.yahoo.com
31st of October 2024
Disposition of 154 shares by Krognes Steve E. of Guardant Health subject to Rule 16b-3 at Krognes Steve E.
Guardant Health Investors Sentiment
The influence of Guardant Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Guardant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Guardant Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Guardant Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Guardant Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Guardant Health's short interest history, or implied volatility extrapolated from Guardant Health options trading.
Check out Guardant Health Backtesting and Guardant Health Hype Analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share | Quarterly Revenue Growth 0.339 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.